Mjs Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 Hyderabad, Telangana, India Active
Last Updated:
About Mjs Pharmaceuticals Private Limited

Mjs Pharmaceuticals Private Limited, a active private limited company, was established on 21 January 2019 in Hyderabad, Telangana, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299TG2019PTC129878. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Nudurumati Naga Siva Kumar (Director), Satya Srinivas Mulukutla (Managing Director). Past directors included Pavan Bhasker Jagannadham Mulukutla, Vidhyavati Biradar Gopal. It is based at Hno 6-273/2D, Plot No 25A Chintal Road 2 Indrasingh Nagar Opp Nalanda High School, Hyderabad, Telangana, 500054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299TG2019PTC129878

  • Registration Number

    129878

  • Incorporation Date

    21 January 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 1 Month
Company report

Mjs Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mjs Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mjs Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Nudurumati Naga Siva Kumar Director 21 Jan 2019 Current
Satya Srinivas Mulukutla Managing Director 25 Jan 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 11 Jan 2021 Past
Pramod Abcsdd Director 25 Jan 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mjs Pharmaceuticals.

Enhance accessibility to Mjs Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Mjs Pharmaceuticals revenue growth over time
Mjs Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mjs Pharmaceuticals?

Unlock access to Mjs Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Mjs Pharmaceuticals?

Unlock and access historical data on people associated with Mjs Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mjs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mjs Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mjs Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Satya Srinivas Mulukutla was appointed as a Managing Director was appointed as a Managing Director on 25 Jan 2019 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

  • Director Appointment

    Nudurumati Naga Siva Kumar was appointed as a Director was appointed as a Director on 21 Jan 2019 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

  • Company Incorporation

    The activity Mjs Pharmaceuticals Private Limited was registered on 21 Jan 2019 with Roc Hyderabad & aged 7 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mjs Pharmaceuticals Private Limited?

The CIN of Mjs Pharmaceuticals Private Limited is U24299TG2019PTC129878.

Where is Mjs Pharmaceuticals Private Limited headquartered?

Mjs Pharmaceuticals Private Limited is headquartered at Hno 6-273/2D, Plot No 25A Chintal Road 2 Indrasingh Nagar Opp Nalanda High School, Hyderabad, Telangana, 500054.

When was Mjs Pharmaceuticals Private Limited incorporated?

Mjs Pharmaceuticals Private Limited was incorporated on 21 January 2019.

Who are the current directors of Mjs Pharmaceuticals Private Limited?

The current directors of Mjs Pharmaceuticals Private Limited are

What is the primary industry of Mjs Pharmaceuticals Private Limited?

The primary industry of Mjs Pharmaceuticals Private Limited is Chemicals.

Is Mjs Pharmaceuticals Private Limited a listed company?

Mjs Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Mjs Pharmaceuticals Private Limited?

The authorized capital of Mjs Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Mjs Pharmaceuticals Private Limited?

The compliance status of Mjs Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available